[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338544-105":59,"doc-detail-338544-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","potential-utility-of-a-proliferation-inducing-ligand-april-in-colorectal-cancer","Potential Utility of A Proliferation-Inducing Ligand (APRIL) in Colorectal Cancer","","APRIL (a proliferation-inducing ligand) is a tumor necrosis factor superfamily member overexpressed across malignant tumors, including colorectal cancer (CRC). It regulates key physiological processes such as immunoglobulin switching and plasmocyte survival, while its pathological roles position APRIL antagonism as a potential target in autoimmune and immunoglobulin disorders. Literature review focuses on APRIL in CRC initiation, and its potential value for early detection and therapeutic targeting. Findings suggest APRIL may function as a CRC biomarker and help identify patients based on concentration, including possible early disease activity.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/potential-utility-of-a-proliferation-inducing-ligand-april-in-colorectal-cancer/338544/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/potential-utility-of-a-proliferation-inducing-ligand-april-in-colorectal-cancer/338544.png","ImageObject",300,407,{"name":92,"@type":93},"Clementine","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is APRIL and where is it involved in disease?","Question",{"text":112,"@type":113},"APRIL is a cytokine member of the tumor necrosis factor superfamily. It is overexpressed in malignant tumors, including colorectal cancer, and is also implicated in immune-related disorders.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which receptors recognize APRIL?",{"text":117,"@type":113},"APRIL is recognized by the cell surface receptors TACI and BCMA. These receptors are largely present on B lymphocytes and plasmacytes, and can also act as decoy receptors.",{"name":119,"@type":110,"acceptedAnswer":120},"How could APRIL be useful for colorectal cancer diagnostics and therapy?",{"text":121,"@type":113},"The review indicates APRIL has significant potential as a CRC biomarker and treatment target. Based on its concentration, APRIL may help identify CRC patients and potentially support early detection of ongoing disease processes.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},338544,1790797319,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374391974564,"https://ap-avatar.wpscdn.com/avatar/14000253aa45c000a9e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779874745381141002","Review  \nPotential Utility of A Proliferation-Inducing Ligand (APRIL) in Colorectal Cancer  \nMonika Zajkowska 1,2, Karolina Orywal 2,3 and Mariusz Gryko 4,5, *  \nCitation: Zajkowska, M.; Orywal, K.; Gryko, M. Potential Utility of A Proliferation-Inducing Ligand (APRIL) in Colorectal Cancer. Int. J. Mol. Sci. 2024, 25, 12496. [https://](https://)[ ](https://)[doi.org/10.3390/ijms252312496](doi.org/10.3390/ijms252312496)  \nAcademic Editor: Carmine Stolfi  \nReceived: 14 October 2024  \nRevised: 17 November 2024  \nAccepted: 19 November 2024  \nPublished: 21 November 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Department of Neurodegeneration Diagnostics, Medical University of Białystok, 15-269 Białystok, Poland; [monika.zajkowska@umb.edu.pl](monika.zajkowska@umb.edu.pl)  \n2 Department of Biochemical Diagnostics, Medical University of Bialystok Clinical Hospital, 15-269 Białystok, Poland; [karolina.orywal@umb.edu.pl](karolina.orywal@umb.edu.pl)  \n3 Department of Biochemical Diagnostics, Medical University of Białystok, 15-269 Białystok, Poland  \n4 Department of Surgical Nursing, Medical University of Białystok, 15-274 Białystok, Poland  \n5 1st Clinical Department of General and Endocrine Surgery, Medical University of Bialystok Clinical Hospital, 15-276 Białystok, Poland  \n* [Correspondence: mariusz.gryko@umb.edu.pl](Correspondence: mariusz.gryko@umb.edu.pl); Tel.: +48-85-686-50-78  \nAbstract: APRIL (A proliferation-inducing ligand) is a member of the tumor necrosis factor superfamily that is overexpressed in a variety of malignant tumors, including colorectal cancer (CRC). Its key physiological roles include inducing the immunoglobulin switch and ensuring plasmocyte survival. In terms of pathological roles, APRIL antagonism has been identified as a key target in autoimmune diseases and immunoglobulin disorders. As previously demonstrated, several inflammatory processes occur at the site of neoplastic initial stages, and their local symptoms are difficult to detect, particularly in the early stages. That is why we chose to study the current literature on APRIL’s role in the development of colorectal cancer. The main objective of our research was to investigate the role of APRIL in cancer initiation and its usefulness in the detection and therapy of CRC. Interestingly, the findings conducted so far show that the selected protein has a significant potential as a CRC biomarker and treatment target. Importantly, based on its concentration, it is possible to identify CRC patients, but whether the lesion has a benign or malignant nature, indicating the possibility of rapid detection of an ongoing disease process.  \nKeywords: TNFSF13; APRIL; CRC; diagnostics; prognosis; screening; therapy  \n1. Introduction  \nThe APRIL (A Proliferation-Inducing Ligand) protein is a cytokine that regulates the immune response as well as cell proliferation and survival. In colorectal cancer, APRIL is gaining interest as a possible biomarker and therapeutic target [1] . According to studies, in pathological circumstances such as cancer, the level of APRIL expression may be altered, affecting disease genesis and progression. Understanding the mechanisms of APRIL action in colorectal cancer may lead to new diagnostic and therapy options, as well as offer understanding on the intricate connections between the immune system and colorectal malignancies [2–5] . Therefore, the aim of our work was to summarize the available literature on APRIL and its involvement in colorectal cancer carcinogenesis, as well as its utility as a possible biomarker and therapeutic target in colorectal cancer.  \n2. Tumor Necrosis Factor Ligand Superfamily Member 13—APRIL ","cbCaib3a7gwFZV1Y","https://ap.wps.com/l/cbCaib3a7gwFZV1Y","pdf",598676,11,"English","# Introduction\n# Tumor Necrosis Factor Ligand Superfamily Member 13—APRIL","[{\"question\":\"What is APRIL and where is it involved in disease?\",\"answer\":\"APRIL is a cytokine member of the tumor necrosis factor superfamily. It is overexpressed in malignant tumors, including colorectal cancer, and is also implicated in immune-related disorders.\"},{\"question\":\"Which receptors recognize APRIL?\",\"answer\":\"APRIL is recognized by the cell surface receptors TACI and BCMA. These receptors are largely present on B lymphocytes and plasmacytes, and can also act as decoy receptors.\"},{\"question\":\"How could APRIL be useful for colorectal cancer diagnostics and therapy?\",\"answer\":\"The review indicates APRIL has significant potential as a CRC biomarker and treatment target. Based on its concentration, APRIL may help identify CRC patients and potentially support early detection of ongoing disease processes.\"}]","Potential Utility of A Proliferation-Inducing Ligand (APRIL) in Colorectal Cancer | PDF",1790024132,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/704c5f8dc986f6ada8db088b61e4b5d1.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5854d874254aa72954bdbaa1e642fdf9.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/df4244e0962154ad5138eef530c74829.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5bf39c514349ee91577d2465bd31b994.webp",980,1385]